Gallego-Murillo JS, Iacono G, van der Wielen LA, van den Akker E, von Lindern M, Wahl SA (2022)
Publication Type: Journal article
Publication year: 2022
DOI: 10.1002/bit.28193
Transfusion of donor-derived red blood cells (RBCs) is the most common form of cell therapy. Production of transfusion-ready cultured RBCs (cRBCs) is a promising replacement for the current, fully donor-dependent therapy. A single transfusion unit, however, contains 2 × 1012 RBC, which requires large scale production. Here, we report on the scale-up of cRBC production from static cultures of erythroblasts to 3 L stirred tank bioreactors, and identify the effect of operating conditions on the efficiency of the process. Oxygen requirement of proliferating erythroblasts (0.55–2.01 pg/cell/h) required sparging of air to maintain the dissolved oxygen concentration at the tested setpoint (2.88 mg O2/L). Erythroblasts could be cultured at dissolved oxygen concentrations as low as 0.7 O2 mg/ml without negative impact on proliferation, viability or differentiation dynamics. Stirring speeds of up to 600 rpm supported erythroblast proliferation, while 1800 rpm led to a transient halt in growth and accelerated differentiation followed by a recovery after 5 days of culture. Erythroblasts differentiated in bioreactors, with final enucleation levels and hemoglobin content similar to parallel cultures under static conditions.
APA:
Gallego-Murillo, J.S., Iacono, G., van der Wielen, L.A., van den Akker, E., von Lindern, M., & Wahl, S.A. (2022). Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors. Biotechnology and Bioengineering. https://dx.doi.org/10.1002/bit.28193
MLA:
Gallego-Murillo, Joan Sebastián, et al. "Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors." Biotechnology and Bioengineering (2022).
BibTeX: Download